Citadel Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-101,329
| Closed | -$468K | – | 5393 |
|
2019
Q1 | $468K | Buy |
+101,329
| New | +$468K | ﹤0.01% | 3429 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 5192 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 4971 |
|
2018
Q2 | – | Sell |
-64,978
| Closed | -$392K | – | 4790 |
|
2018
Q1 | $392K | Sell |
64,978
-92,868
| -59% | -$560K | ﹤0.01% | 3085 |
|
2017
Q4 | $1.52M | Sell |
157,846
-25,900
| -14% | -$249K | ﹤0.01% | 2092 |
|
2017
Q3 | $1.63M | Buy |
183,746
+112,338
| +157% | +$998K | ﹤0.01% | 1951 |
|
2017
Q2 | $903K | Buy |
71,408
+53,310
| +295% | +$674K | ﹤0.01% | 2223 |
|
2017
Q1 | $190K | Sell |
18,098
-54,488
| -75% | -$572K | ﹤0.01% | 3201 |
|
2016
Q4 | $668K | Sell |
72,586
-315,097
| -81% | -$2.9M | ﹤0.01% | 2272 |
|
2016
Q3 | $4.57M | Buy |
+387,683
| New | +$4.57M | ﹤0.01% | 1117 |
|
2016
Q2 | – | Hold |
0
| – | – | – | 4164 |
|
2016
Q1 | – | Sell |
-446,129
| Closed | -$12.8M | – | 4253 |
|
2015
Q4 | $12.8M | Sell |
446,129
-520,288
| -54% | -$14.9M | 0.01% | 756 |
|
2015
Q3 | $27.5M | Buy |
966,417
+767,504
| +386% | +$21.8M | 0.03% | 515 |
|
2015
Q2 | $7.14M | Buy |
198,913
+52,997
| +36% | +$1.9M | 0.01% | 1099 |
|
2015
Q1 | $4.24M | Buy |
145,916
+118,510
| +432% | +$3.44M | ﹤0.01% | 1355 |
|
2014
Q4 | $577K | Sell |
27,406
-19,386
| -41% | -$408K | ﹤0.01% | 2470 |
|
2014
Q3 | $907K | Sell |
46,792
-18,230
| -28% | -$353K | ﹤0.01% | 2050 |
|
2014
Q2 | $1.02M | Buy |
65,022
+28,370
| +77% | +$443K | ﹤0.01% | 1839 |
|
2014
Q1 | $760K | Sell |
36,652
-67,253
| -65% | -$1.39M | ﹤0.01% | 2039 |
|
2013
Q4 | $1.34M | Buy |
103,905
+77,232
| +290% | +$997K | ﹤0.01% | 1528 |
|
2013
Q3 | $311K | Buy |
+26,673
| New | +$311K | ﹤0.01% | 2101 |
|